Does ADO-TRASTUZUMAB EMTANSINE Cause Epistaxis? 327 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 327 reports of Epistaxis have been filed in association with ADO-TRASTUZUMAB EMTANSINE. This represents 3.8% of all adverse event reports for ADO-TRASTUZUMAB EMTANSINE.
327
Reports of Epistaxis with ADO-TRASTUZUMAB EMTANSINE
3.8%
of all ADO-TRASTUZUMAB EMTANSINE reports
19
Deaths
91
Hospitalizations
How Dangerous Is Epistaxis From ADO-TRASTUZUMAB EMTANSINE?
Of the 327 reports, 19 (5.8%) resulted in death, 91 (27.8%) required hospitalization, and 12 (3.7%) were considered life-threatening.
Is Epistaxis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADO-TRASTUZUMAB EMTANSINE. However, 327 reports have been filed with the FAERS database.
What Other Side Effects Does ADO-TRASTUZUMAB EMTANSINE Cause?
Nausea (780)
Fatigue (774)
Disease progression (750)
Diarrhoea (654)
Off label use (630)
Thrombocytopenia (519)
Death (509)
Neuropathy peripheral (506)
Headache (465)
Platelet count decreased (453)
What Other Drugs Cause Epistaxis?
RIVAROXABAN (5,629)
ASPIRIN (3,214)
APIXABAN (2,831)
FLUTICASONE (1,745)
TREPROSTINIL (1,726)
CLOPIDOGREL BISULFATE (1,560)
BEVACIZUMAB (1,542)
WARFARIN (1,498)
PALBOCICLIB (1,280)
ADALIMUMAB (1,243)
Which ADO-TRASTUZUMAB EMTANSINE Alternatives Have Lower Epistaxis Risk?
ADO-TRASTUZUMAB EMTANSINE vs ADRIAMYCIN
ADO-TRASTUZUMAB EMTANSINE vs ADUCANUMAB
ADO-TRASTUZUMAB EMTANSINE vs ADUCANUMAB-AVWA
ADO-TRASTUZUMAB EMTANSINE vs ADVAIR
ADO-TRASTUZUMAB EMTANSINE vs ADVAIR HFA